| 常用名 | 德扎利塞 | CAS号 | 1262440-25-4 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: A novel potent, selective, orally available PI3Kδ inhibitor with IC50 of 31 nM; displays 74 to >900-fold selectivity for the other PI3K family members, and does not inhibit a panel of 57 additional kinases; potently inhibits cellular proliferation CD19+ human or CD21+ canine primary B cells with IC50 of 1-3 nM, reduces anti-FcR-induced basophil activation in the presence of human whole blood (IC50=33 nM); demonstrates promising efficacy in patients with Hodgkin's lymphoma in clinical studies. Blood Cancer Phase 2 Clinical 物理化学性质: CAS号:1262440-25-4 常用中文名:德扎利塞 常用英文名:INCB040093 分子式:C20H16FN7OS 分子量:421.451 密度:1.6±0.1 g/cm3 沸点:N/A 熔点:N/A 闪点:N/A |